Clinical and ultrasound assessment of the therapeutic response to ixekizumab in psoriatic arthritis dactlylitis; a multicentre, parallel-groups, randomised controlled trial
This research study is about finding the best way to treat a specific problem in psoriatic arthritis called dactylitis. Dactylitis is when your fingers or toes become swollen and painful, often looking like 'sausage digits'. We want to see how effective two different medicines are at reducing these symptoms. One medicine is called Taltz (ixekizumab), and the other is Metoject (methotrexate). We'll be comparing Taltz on its own against Metoject on its own. Doctors will use a special score and ultrasound scans to accurately measure how much the swelling in fingers and toes improves. This study aims to give clearer information to help people with psoriatic arthritis and their doctors choose the most effective treatment for dactylitis.
At a glance
What is this study about?
This study is a clinical trial designed to carefully test and compare two treatments for a condition called psoriatic arthritis, or PsA. Specifically, it focuses on a common and often painful symptom of PsA known as dactylitis. Dactylitis causes entire fingers or toes to become very swollen and tender, which can make everyday activities difficult. The main goal is to understand which of two medicines works better for controlling this swelling and improving comfort.
The two medicines being compared are ixekizumab, sold under the brand name Taltz, and methotrexate, often known as Metoject. Taltz is a newer treatment that helps calm down the immune system, which is overactive in conditions like psoriatic arthritis. Metoject is a more established treatment for arthritis. By comparing these two, researchers hope to provide clearer guidance for doctors and patients on the best approach for treating dactylitis.
To measure how well the treatments work, doctors in the study will use special assessments. This includes a score called DACTOS, which helps them track changes in dactylitis. They will also use ultrasound scans, a safe imaging technique, to look closely at the swelling and inflammation inside the fingers and toes. This detailed approach allows them to get a very clear picture of how each medicine affects the condition, helping to confirm which treatment is most effective.
Key takeaways
- Compares two medicines, Taltz and Metoject, for psoriatic arthritis dactylitis.
- Aims to find out which medicine better reduces 'sausage' fingers and toes.
- Uses special scores and ultrasound scans to track swelling improvements.
- Involves regular clinic visits, injections, and health checks.
- Helps advance understanding of dactylitis treatment for future patients.
Who may be eligible?
This study is looking for adults aged 18 or older who have psoriatic arthritis (PsA). Both men and women are welcome to take part.
To be considered, you would need to have specific signs of dactylitis – that's the painful swelling in your fingers or toes – that your doctor can confirm. There will be other health checks to make sure the study medication is safe and suitable for you.
Before you can join, your study doctor will review all your medical information in detail to make sure you meet every requirement for the study. Some conditions or medications might mean you can't participate, as the study needs to be sure it's safe for everyone involved and that the results are clear.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Do you have a diagnosis of psoriatic arthritis (PsA)?
- Have you experienced dactylitis (swollen fingers or toes) due to your PsA?
- Are you able to attend regular clinic appointments?
What does participation involve?
If you decide to take part in this study, you would be randomly assigned to receive either Taltz or Metoject. This means a computer decides which treatment you get, much like flipping a coin, so it’s fair. You won’t get both treatments at the same time.
Taking part involves a number of visits to the study clinic over a period of time. At these visits, you'll have regular check-ups with the study doctors and nurses. This will include physical examinations, blood tests, and ultrasound scans of your affected fingers and toes to track your dactylitis. You will also be asked to complete questionnaires about your symptoms and how you are feeling.
Both Taltz and Metoject are given by injection. The study team will teach you how to administer the injections if you need to do them at home, or they may be given at the clinic. The total time you would be involved in the study, including treatment and follow-up assessments, would be carefully explained by the study team.
Potential risks and benefits
Locations (1)
- —UnverifiedItaly
Common questions
What is dactylitis?
Dactylitis is when your fingers or toes become swollen, painful, and often look like 'sausage digits'. It's a common symptom of psoriatic arthritis.
What are Taltz and Metoject?
Taltz (ixekizumab) and Metoject (methotrexate) are medicines used to treat conditions like psoriatic arthritis. This study is comparing how well they work for dactylitis.
Will I know which treatment I'm getting?
Because this is a comparative study, you will be randomly assigned to receive one of the two treatments. The research team will explain whether you will know which treatment you are on.
What is an ultrasound scan?
An ultrasound scan is a safe and painless way for doctors to look at the tissues inside your fingers and toes using sound waves, helping them to see the swelling.
How long will the study last?
The study team will tell you the exact length of time you will be involved, including all appointments and follow-up checks.
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.